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MC2 CORRECTING FOR COMPENSATING MECHANISMS RELATED TO PRODUCTIVITY COSTS IN ECONOMIC EVALUATIONS OF HEALTH CARE PROGRAMS

MC3 QALYS LACK QUALITY IN PAEDIATRIC CARE: A CRITICAL REVIEW OF PUBLISHED COST-UTILITY STUDIES IN CHILD HEALTH
Griebsch I, Brown J University of Bristol, Bristol, UK OBJECTIVES: To critically appraise published cost-utility analyses of interventions in child and adolescent health care in terms of the methods used to estimate quality-adjusted life years (QALYs). METHODS: A comprehensive search of computerised databases (e.g. Medline, Embase) was undertaken to identify cost-utility studies published prior to April 2004. Studies were categorised according to the methods used to describe health status, the valuation technique and source of preferences. The methods were compared with the guidelines of the U.S. Panel on Cost-effectiveness in Health and Medicine and the National Institute for Clinical Excellence (NICE) in England and Wales which recommend the use of a generic health status classification system (e.g. HUI, EQ-5D), a choice-based valuation method (e.g. SG or TTO), and preferences of the general population. RESULTS: Fifty-four studies were reviewed, of which 34 (63%) were published in the latter 5 years. A generic health status classification instrument was used in 22 (35%) cases; the remainder developed study specific health state descriptions or elicited preferences directly from patients or proxies. In 7 cases (11%), sources were unclear. Utility values were elicited by using choicebased techniques in 28 cases (42%), either as tariffs for health status classification instruments (17 cases) or by directly valuing health state descriptions or patient health (11 cases). Community preferences were only used in 23 cases (37%). Four studies aggregated QALYs for mother/child or family/child pairs without giving any theoretical justification. CONCLUSIONS: Although the number of cost utility studies is increasing exponentially, the majority of studies did not adhere to standard recommendations with little improvement over time. Further research is warranted to develop appropriate methods to measure and value child health benefits within the QALY framework. In the interim, an expert panel is needed to provide guidance for cost-utility analysis of paediatric interventions to make studies more consistent.
MC4 FLEXIBILITY AND TRANSPARENCY OF BAYESIAN NETWORKS: MODELING THE ECONOMIC IMPACT OF DRUG-ELUTING CORONARY STENTS
Marchetti M, Barosi G IRCCS Policlinico San Matteo, Pavia, Italy OBJECTIVE: Drug-eluting stents (DES) elute drugs that prevent coronary restenosis after a percutaneous revascularization. The cost of DES is quite high therefore imposing a relevant burden to hospital and NHS budgets. Patients selection and reimbursement policies need to be settled according to a large amount of clinical (number and anatomy of revascularized vessels, diabetes, unstable angina), economic (local cost of devices and procedures) and organizational variables (adoption rate of different types of DES and BMS, number of stent/procedure, shift from surgical to DES revascularization). The resulting decision models are usually blamed for high complexity but poor completeness and low transparency. METHODS: Bayesian networks (BN) are close acyclic graphs displaying value nodes, probability nodes and, possibly, decision nodes (influence diagrams). We explored the application of BN to policy selection for DES use, in both the NHS and the hospital perspective. Three commercial softwares were compared: Netica, TreeAgePro, HuginLite. Beta and gamma distributions were used to represent the probability of conditions/events and unit costs, respectively. Log-normal distributions were used to model relative risks. RESULTS: BN modeling of the DES problem was feasible with the three softwares and required 35-40 nodes. We tested five types of restriction policies to DES use, anchored to: 1) the presence of diabetes; 2) the number of vessels to be revascularized; 3) the overall risk of restenosis; 4) a cutoff adoption rate of DES; and 5) a cutoff budget. We could verify that flexibility, directness and transparency varied among the softwares. Also software modalities to manage uncertainty and to report the results had different appeal. CONCLUSIONS: BN allows rapid and transparent estimations of the local/specific economic impact of several differ-
